Eptinezumab
Modify Date: 2024-01-13 13:21:43
Eptinezumab structure
|
Common Name | Eptinezumab | ||
|---|---|---|---|---|
| CAS Number | 1644539-04-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EptinezumabEptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1]. |
| Name | Eptinezumab |
|---|
| Description | Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Dhillon S. Eptinezumab: First Approval. Drugs. 2020;80(7):733-739. |
| No Any Chemical & Physical Properties |